p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Clinical trial NCT02098343 · COMPLETED

Trial details

NCT number: NCT02098343
Sponsor: Aprea Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

Start date: 2014-03-01
Primary completion: 2019-04-01
Enrollment: 247

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.